Diligence memo · auto-generated · as of July 2, 2026
AshHill PharmaFund I, LLC
AshHill PharmaFund I, LLC looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
AshHill PharmaFund I, LLC operates in Pharmaceuticals, based in FT. THOMAS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
AshHill PharmaFund I, LLC has raised $25M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on —.
Valuation (modeled)modeled
Provath models AshHill PharmaFund I, LLC at approximately $79M (range $53M–$97M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.15× the median modeled value of Series B Pharmaceuticals companies (270 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 70% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 51% of those peers.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.